UK Industry Welcomes R&D Measures In Chancellor’s Autumn Statement

 
• By Ian Schofield

Faced with a predicted sharp decline in economic growth as a result of the Brexit vote, the UK Chancellor of the Exchequer has fleshed out proposals for supporting R&D and innovation that have been welcomed by the biopharmaceutical industry.

Withdrawal
The UK government has proposed measures to support innovation R&D in the face of Brexit

More from Government Payers

More from Market Access